RESUMEN
Studies of the mechanism of benzo[a]pyrene metabolism to reactive diol epoxides and of their disposition indicate that the metabolic intermediates of the activation pathways, 7,8-epoxide and trans-7,8-diol, as well as the two stereoisomeric diol epoxides are all optically active. Benzo[a]pyrene is converted to optically active 9,10-epoxides of (-)trans-7,8-diol by three enzymatic steps: (i) stereospecific oxygenation at the 7,8 double bond of benzo[a]pyrene by the mixed-function oxidases to essentially a single enantiomer of 7,8-epoxide, (ii) hydration of the 7,8-epoxide by epoxide hydratase to an optically pure (-)trans-7,8-diol, and (iii) stereoselective oxygenation by the mixed-function oxidases at the 9,10 double bond of the (-) trans-7,8-diol to optically active r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene and optically active r-7,t-8-dihydroxy-c-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene in a ratio of approximately 10 to 1.
Asunto(s)
Benzopirenos , Epóxido Hidrolasas/metabolismo , Hidroliasas/metabolismo , Microsomas Hepáticos/metabolismo , Oxigenasas de Función Mixta/metabolismo , Oxidorreductasas/metabolismo , Animales , Benzopirenos/metabolismo , Éteres Cíclicos/metabolismo , Microsomas Hepáticos/enzimología , Ratas , EstereoisomerismoRESUMEN
Mouse skin contains aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity which is inducible by aromatic polycyclic hydrocarbons and benzoflavones. The duration and magnitude of induction, but not the initial kinetics, are dependent on the inducer dose. The cutaneous hydroxylase activity is inhibited by carbon monoxide and requires the presence of NADPH, indicating that the enzyme is one of the mixed-function oxygenases. The highest enzyme activity was found in the superficial layer of skin which contains the sebaceous glands and the upper pilary canals. Enzyme activities were intermediate in the epidermis and lowest in the deeper dermal layers.
Asunto(s)
Oxigenasas de Función Mixta/metabolismo , Piel/enzimología , Animales , Antracenos/administración & dosificación , Antracenos/farmacología , Benzopirenos , Monóxido de Carbono/farmacología , Inducción Enzimática/efectos de los fármacos , Flavonoides/farmacología , Inyecciones Intraperitoneales , Cinética , Hígado/enzimología , Pulmón/enzimología , Metilcolantreno/farmacología , Ratones , NADP/farmacología , Naftacenos/farmacología , Fenantrenos/farmacologíaAsunto(s)
9,10-Dimetil-1,2-benzantraceno/metabolismo , Benzo(a)Antracenos/metabolismo , Benzopirenos/metabolismo , Bronquios/metabolismo , Conductos Pancreáticos/metabolismo , 9,10-Dimetil-1,2-benzantraceno/farmacología , Hidrocarburo de Aril Hidroxilasas/biosíntesis , Benzopirenos/farmacología , ADN/metabolismo , Inducción Enzimática/efectos de los fármacos , Humanos , Neoplasias Pulmonares/metabolismo , Técnicas de Cultivo de ÓrganosAsunto(s)
Tejido Conectivo/metabolismo , Granuloma/metabolismo , Inflamación/metabolismo , Monosacáridos/metabolismo , Nucleótidos/metabolismo , Animales , Antimetabolitos/farmacología , Isótopos de Carbono , Granuloma/inducido químicamente , Cobayas , Hexosaminas/metabolismo , Hidrocortisona/farmacología , Hígado/metabolismo , Polivinilos/farmacologíaAsunto(s)
Benzo(a)Antracenos/farmacología , Benzopirenos/metabolismo , Microsomas Hepáticos/enzimología , Oxigenasas de Función Mixta/metabolismo , Compuestos Policíclicos/farmacología , Acetona , Animales , Antracenos/farmacología , Dimetilsulfóxido , Inducción Enzimática , Técnicas In Vitro , Metanol , Metilcolantreno/farmacología , Oxigenasas de Función Mixta/antagonistas & inhibidores , Naftalenos/farmacología , Fenantrenos/farmacología , RatasRESUMEN
1. Metabolism of 14C-labelled benzo[a]pyrene (-)trans-7,8-dihydrodiol to protein- and DNA-binding products in a reconstituted enzyme system proceeds 5 to 10 times faster with rabbit cytochrome P-450 LM4 than with LM2. 2. Either cytochrome converts the substrate to ethyl acetate- and water-soluble metabolites, identified by h.p.l.c. Water-soluble metabolites comprise 78% of the total products with cytochrome P-450 LM2, but only 50% of those formed by LM4. The relative proportion of the two types of metabolites is differentially affected by certain modifiers such as 7,8-benzoflavone. 3. Half of the radioactivity in the aqueous phase of reaction mixtures containing cytochrome P-450 LM4 represents (-)trans-7,8-diol metabolites in complex primarily with NADPH and phosphate. The remaining water-soluble products are bound covalently to proteins in the reconstituted system. 4. Polyacrylamide gel electrophoresis, autoradiography, and measurement of the radioactivity in individual bands indicate that a larger fraction of metabolites is bound to cytochrome P-450 LM4 than to NADPH-cytochrome P-450 reductase, and only marginal binding to cytochrome P-450 LM2 is seen. Metabolite binding to added DNA is likewise substantially greater in magnitude when cytochrome P-450 LM4, as opposed to LM2, catalyses (-)trans-7,8-diol oxygenation. Thus, the degree of metabolite binding to monoxygenase proteins and to DNA correlates well with the catalytic activity of cytochrome P-450 LM4 and LM2 towards (-)trans-7,8-diol. 5. DNA causes a dramatic enhancement in the activity of cytochrome P-450 LM4 with (-)trans-7,8-diol, indicating that the cytochrome and/or the reductase may be functionally impaired by metabolites of this substrate. Such an effect may alter the balance between detoxication and activation of the carcinogenic benzo[a]pyrene.
Asunto(s)
Sistema Enzimático del Citocromo P-450/metabolismo , Dihidroxidihidrobenzopirenos/metabolismo , Microsomas Hepáticos/enzimología , NADPH-Ferrihemoproteína Reductasa/metabolismo , Animales , Benzoflavonas/farmacología , Biotransformación , Catálisis , Cromatografía Líquida de Alta Presión , ADN/metabolismo , Ácido Desoxicólico/farmacología , Técnicas In Vitro , Microsomas Hepáticos/efectos de los fármacos , Unión Proteica , Conejos , EstereoisomerismoRESUMEN
Highly purified cytochromes P-450(LM2) and P-450(LM4) and partially purified P-450(LM1), P-450(LM3b), and P-450(LM7) from rabbit liver microsomes exhibit different catalytic activities in the metabolism of benzo[a]pyrene (BzP) and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene [(-)trans-7,8-diol] in a reconstituted enzyme system. The two highly purified cytochromes also exhibit differences in the activation of BzP and (-)trans-7,8-diol to intermediates that bind to DNA, as well as in the stereoselective conversion of (-)trans-7,8-diol to the highly mutagenic and carcinogenic diol-epoxides r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10- tetrahydrobenzo[a]pyrene (diol-epoxide I) and r - 7,t - 8 - dihydroxy - c - 9,10 - oxy - 7,8,9,10 - tetrahydrobenzo[a]pyrene (diol-epoxide II). P-450(LM2) is more active than P-450(LM4) in the metabolism of BzP and in its conversion to products that bind to DNA. In contrast, P-450(LM4) is more active than P-450(LM2) in the metabolism of (-)trans-7,8-diol and in its conversion to products that bind to DNA. The ratio of activity (percent substrate metabolized) with BzP relative to that with (-)trans-7,8-diol is 21 for P-450(LM2) and 0.3 for P-450(LM4); P-450(LM1), P-450(LM3b), and P-450(LM7) gave intermediate ratios. Marked stereoselectivity in the oxygenation of the (-)trans-7,8-diol to the highly mutagenic and putatively carcinogenic diol-epoxides I and II was observed with P-450(LM4), whereas the other preparations showed less selectivity. The ratio of diolepoxide I to diol-epoxide II ranges from 0.3 for P-450(LM7) to 11 for P-450(LM4). The substrate specificity and regio- and stereo-selectivity of the different forms of cytochrome P-450 may regulate the balance between activation and detoxification pathways of BzP and therefore determine the susceptibility of individual tissues, strains, and species to the carcinogenic action of BzP.